Skip to main content

3 Reasons to Avoid PRLB and 1 Stock to Buy Instead

PRLB Cover Image

Over the past six months, Proto Labs has been a great trade, beating the S&P 500 by 33.6%. Its stock price has climbed to $67.52, representing a healthy 39.6% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Is there a buying opportunity in Proto Labs, or does it present a risk to your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Do We Think Proto Labs Will Underperform?

Despite the momentum, we're sitting this one out for now. Here are three reasons you should be careful with PRLB and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

A company’s long-term performance is an indicator of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Unfortunately, Proto Labs’s 4.2% annualized revenue growth over the last five years was sluggish. This fell short of our benchmark for the industrials sector.

Proto Labs Quarterly Revenue

2. EPS Trending Down

Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions.

Sadly for Proto Labs, its EPS declined by 7% annually over the last five years while its revenue grew by 4.2%. This tells us the company became less profitable on a per-share basis as it expanded.

Proto Labs Trailing 12-Month EPS (Non-GAAP)

3. Previous Growth Initiatives Haven’t Paid Off Yet

Growth gives us insight into a company’s long-term potential, but how capital-efficient was that growth? A company’s ROIC explains this by showing how much operating profit it makes compared to the money it has raised (debt and equity).

Proto Labs’s five-year average ROIC was negative 1%, meaning management lost money while trying to expand the business. Its returns were among the worst in the industrials sector.

Proto Labs Trailing 12-Month Return On Invested Capital

Final Judgment

We see the value of companies helping their customers, but in the case of Proto Labs, we’re out. With its shares beating the market recently, the stock trades at 37.6× forward P/E (or $67.52 per share). This valuation tells us it’s a bit of a market darling with a lot of good news priced in - you can find more timely opportunities elsewhere. We’d suggest looking at one of our all-time favorite software stocks.

Stocks We Like More Than Proto Labs

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  201.18
+2.39 (1.20%)
AAPL  263.88
+8.10 (3.17%)
AMD  203.08
-4.24 (-2.05%)
BAC  52.74
+0.19 (0.36%)
GOOG  302.82
-3.20 (-1.05%)
META  639.26
-0.51 (-0.08%)
MSFT  396.86
-4.46 (-1.11%)
NVDA  184.97
+2.16 (1.18%)
ORCL  153.97
-6.17 (-3.85%)
TSLA  410.63
-6.81 (-1.63%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.